Timing of troponin I measurement in pulmonary embolism

Heart

Volumn 98, Issue 9, 2012, Pages 732-735

  Ferrari, Emile ^a   Moceri, Pamela ^a   Crouzet, Christophe ^a   Doyen, Denis ^a   Cerboni, Pierre ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HEMODYNAMICS; HOSPITAL PATIENT; HUMAN; KINETICS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TROPONIN I; YOUNG ADULT;

EID: 84860186420     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301724     Document Type: Article

References (24)

1. Giannitsis E, Müller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-17. (Pubitemid 30451779)
2. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000;36:1632-6.
3. Tulevski II, Hirsch A, Sanson BJ, et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 2001;86:1193-6. (Pubitemid 33064567)
4. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002;106:1263-8. (Pubitemid 34988646)
5. Mehta NJ, Jani K, Khan IA. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am Heart J 2003;145:821-5. (Pubitemid 36570952)
6. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003;123:1947-52. (Pubitemid 36706716)
7. Punukollu G, Khan IA, Gowda RM, et al. Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms. Int J Cardiol 2005;99:207-11. (Pubitemid 40320791)
8. Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003;326:312-13. (Pubitemid 36205164)
9. Pruszczyk P, Kostrubiec M, Bochowicz A, et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003;225:649-53. (Pubitemid 37258545)
10. Krüger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004;147:60-5. (Pubitemid 38037398)
11. Kucher N, Printzen G, Doernhoefer T, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003;107:1576-8. (Pubitemid 36397323)
12. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003;108:2191-4. (Pubitemid 37363033)
13. Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 2007;116:161-6.
14. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of cardiology (ESC). Eur Heart J 2008;29:2276-315.
15. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:454S-545S. (Pubitemid 351892971)
16. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet 1999;353:1386-9. (Pubitemid 29192409)
17. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
18. Jenkins PO, Sultanzadeh J, Bhagwat M, et al. Should thrombolysis have a greater role in the management of pulmonary embolism? Clin Med 2009;9:431-5.
19. Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: past, present and future. Thromb Haemost 2010;103:877-83.
20. Orde MM, Puranik R, Morrow PL, et al. Myocardial pathology in pulmonary thromboembolism. Heart 2011;97:1695-9.
21. Muller-Bardorff M, Weidtmann B, Giannitisis E, et al. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem 2002;48:673-5. (Pubitemid 34261240)
22. PEITHO Pulmonary Embolism Thrombolysis Trial. NCT00639743. March 13, 2008. last updated: January 21, 2011. http://clinicaltrials.gov/ct2/show/ NCT00639743 (accessed 11 Mar 2012).
23. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788-830.
24. Douketis JD, Leeuwenkamp O, Grobara P, et al. The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. J Thromb Haemost 2005;3:508-13. (Pubitemid 41632876)